0000902664-24-003030.txt : 20240423
0000902664-24-003030.hdr.sgml : 20240423
20240423161531
ACCESSION NUMBER: 0000902664-24-003030
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240419
FILED AS OF DATE: 20240423
DATE AS OF CHANGE: 20240423
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nichols Weston
CENTRAL INDEX KEY: 0001746376
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40603
FILM NUMBER: 24864991
MAIL ADDRESS:
STREET 1: 151 CALLE DE SAN FRANCISCO
STREET 2: SUITE 200, PMB 1237
CITY: SAN JUAN
STATE: PR
ZIP: 00901-1607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lynx1 Capital Management LP
CENTRAL INDEX KEY: 0001910456
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40603
FILM NUMBER: 24864992
BUSINESS ADDRESS:
STREET 1: 151 CALLE DE SAN FRANCISCO
STREET 2: SUITE 200 PMB 1237
CITY: SAN JUAN
STATE: PR
ZIP: 00901-1607
BUSINESS PHONE: 703-963-7214
MAIL ADDRESS:
STREET 1: 151 CALLE DE SAN FRANCISCO
STREET 2: SUITE 200 PMB 1237
CITY: SAN JUAN
STATE: PR
ZIP: 00901-1607
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TScan Therapeutics, Inc.
CENTRAL INDEX KEY: 0001783328
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 825282075
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 880 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 857-399-9500
MAIL ADDRESS:
STREET 1: 880 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
ownership.xml
X0508
4
2024-04-19
0
0001783328
TScan Therapeutics, Inc.
TCRX
0001910456
Lynx1 Capital Management LP
151 CALLE DE SAN FRANCISCO
SUITE 200 PMB 1237
SAN JUAN
PR
00901-1607
PUERTO RICO
0
0
1
0
0001746376
Nichols Weston
151 CALLE DE SAN FRANCISCO
SUITE 200 PMB 1237
SAN JUAN
PR
00901-1607
PUERTO RICO
0
0
1
0
0
Pre-funded Warrant (right to buy)
0.0001
2024-04-19
4
P
0
5000000
7.1299
A
Common Stock
5000000
5000000
I
See footnote
Subject to the terms and conditions set forth in the Pre-funded Warrant, the holder thereof may, at any time and from time to time on or after April 19, 2024, exercise the Pre-funded Warrant until it has been exercised in full. The Pre-funded Warrants reported herein contain an exercise limitation prohibiting the holder from exercising the Pre-Funded Warrants until such time as the holder, together with the Reporting Persons and certain other related parties, would not beneficially own after any such exercise more than 4.99% of the then issued and outstanding Common Stock (the "Blocker"). Due to the Blocker, the Pre-funded Warrants beneficially owned by the Reporting Persons are not presently exercisable.
The securities to which this filing relates are held directly by Lynx1 Master Fund LP to which Lynx1 Capital Management LP (the "Investment Manager") serves as investment manager. Weston Nichols ("Mr. Nichols") is the sole member of Lynx1 Capital Management GP LLC, the general partner of the Investment Manager. Each of the Investment Manager and Mr. Nichols disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any.
Lynx1 Capital Management LP, By: Lynx1 Capital Management GP LLC, its general partner, By: /s/ Weston Nichols, Sole Member
2024-04-23
/s/ Weston Nichols
2024-04-23